1. Yamchi, A., Madanchi, H., Khazaei, V., Behrouzikhah, M., Abbasi, H., Salehi, M., Moradi, N., & Sanami, S. (2024). Designing a multi-epitope vaccine against the SARS-CoV-2 variant based on an immunoinformatics approach. Current Computer-Aided Drug Design, 20(3), 274–290.
2. Lahimchi, M. R., Madanchi, H., Ahmadi, K., Shahbazi, B., & Yousefi, B. (2024). In silico designing a novel TLR4-mediating multiepitope vaccine against monkeypox via advanced immunoinformatics and bioinformatics approaches. Journal of Biomolecular Structure and Dynamics, 42(4), 2094–2110.
3. Khadijeh, A., Farasat, A., Rostamian, M., Johari, B., & Madanchi, H. (2021). Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: An in silico drug repurposing study. Journal of Biomolecular Structure and Dynamics.
4. Eivazzadeh-Keihan, R., Radinekiyan, F., Aliabadi, H. A. M., & Madanchi, H. (2021). Chitosan hydrogel/silk fibroin/Mg(OH)₂ nanobiocomposite as a novel scaffold with antimicrobial activity and improved mechanical properties. Scientific Reports, 11, 650.
5. Madanchi, H., Kiasari, R. E., Mousavi, S. J., Johari, B., Shabani, A. A., & Sardari, S. (2020). Design and synthesis of lipopolysaccharide-binding antimicrobial peptides based on truncated rabbit and human CAP18 peptides and evaluation of their action mechanism. Probiotics and Antimicrobial Proteins, 12(3), 853–864.